The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury

Acute lung injury (ALI) is a disease, with no effective treatment, which might result in death. Formations of excessive inflammation and oxidative stress are responsible for the pathophysiology of ALI. Nebivolol (NBL), a third-generation selective β1 adrenoceptor antagonist, has protective pharmacological properties, such as anti-inflammatory, anti-apoptotic, and antioxidant functions. Consequently, we sought to assess the efficacy of NBL on a lipopolysaccharide (LPS)-induced ALI model via intercellular adhesion molecule-1 (ICAM-1) expression and the tissue inhibitor of metalloproteinases-1 (TIMP-1)/matrix metalloproteinases-2 (MMP-2) signaling. Thirty-two rats were split into four categories: control, LPS (5 mg/kg, intraperitoneally [IP], single dose), LPS (5 mg/kg, IP, one dosage 30 min after last NBL treatment), + NBL (10 mg/kg oral gavage for three days), and NBL (10 mg/kg oral gavage for three days). Six hours after the administration of LPS, the lung tissues of the rats were removed for histopathological, biochemical, gene expression, and immunohistochemical analyses. Oxidative stress markers such as total oxidant status and oxidative stress index levels, leukocyte transendothelial migration markers such as MMP-2, TIMP-1, and ICAM-1 expressions in the case of inflammation, and caspase-3 as an apoptotic marker, significantly increased in the LPS group. NBL therapy reversed all these changes. The results of this study suggest that NBL has utility as a potential therapeutic agent to dampen inflammation in other lung and tissue injury models

[1]  A. Picca,et al.  Circulating Inflammatory, Mitochondrial Dysfunction, and Senescence-Related Markers in Older Adults with Physical Frailty and Sarcopenia: A BIOSPHERE Exploratory Study , 2022, International journal of molecular sciences.

[2]  A. Krüger,et al.  Cut loose TIMP-1: an emerging cytokine in inflammation. , 2022, Trends in cell biology.

[3]  F. Bikker,et al.  Is TIMP‐1 a biomarker for periodontal disease? A systematic review and meta‐analysis , 2021, Journal of periodontal research.

[4]  J. Pietkiewicz,et al.  Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury—Cardioprotective Properties of Carvedilol , 2021, Pharmaceuticals.

[5]  Hongqiang Cheng,et al.  Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages , 2021, Nature Communications.

[6]  M. Çiriş,et al.  Nebivolol alleviates liver damage caused by methotrexate via AKT1/Hif1α/eNOS signaling , 2021, Drug and chemical toxicology.

[7]  M. Martinez-Fierro,et al.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases , 2020, International journal of molecular sciences.

[8]  C. R. Tirapelli,et al.  Nebivolol Prevents Up-Regulation of Nox2/NADPH Oxidase and Lipoperoxidation in the Early Stages of Ethanol-Induced Cardiac Toxicity , 2020, Cardiovascular Toxicology.

[9]  Lixin Xie,et al.  Mesenchymal stem cells reverse EMT process through blocking the activation of NF-κB and Hedgehog pathways in LPS-induced acute lung injury , 2020, Cell Death & Disease.

[10]  S. Hwang,et al.  A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation , 2020, Theranostics.

[11]  R. Sumagin,et al.  ICAM‐1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis , 2020, Journal of leukocyte biology.

[12]  O. Osipova,et al.  [Effect of pharmacotherapy on collagen metabolism in patients with heart failure with middle range ejection fraction of senile age.] , 2020, Advances in gerontology = Uspekhi gerontologii.

[13]  J. Zhan,et al.  Irisin alleviates pulmonary epithelial barrier dysfunction in sepsis-induced acute lung injury via activation of AMPK/SIRT1 pathways. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  D. Mokra,et al.  Corticosteroids in Acute Lung Injury: The Dilemma Continues , 2019, International journal of molecular sciences.

[15]  D. Grimm,et al.  Nebivolol in the Treatment of Arterial Hypertension. , 2019, Basic & clinical pharmacology & toxicology.

[16]  A. Calkovska,et al.  Alveolar-Capillary Membrane-Related Pulmonary Cells as a Target in Endotoxin-Induced Acute Lung Injury , 2019, International journal of molecular sciences.

[17]  J. Song,et al.  The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[18]  Yafeng Liang,et al.  Elevated IL-33 promotes expression of MMP2 and MMP9 via activating STAT3 in alveolar macrophages during LPS-induced acute lung injury , 2018, Cellular & molecular biology letters.

[19]  V. Askari,et al.  Immunomodulatory properties of captopril, an ACE inhibitor, on LPS-induced lung inflammation and fibrosis as well as oxidative stress , 2018, Inflammopharmacology.

[20]  Guan-Jhong Huang,et al.  Ginsenoside Rh2 Ameliorates Lipopolysaccharide-Induced Acute Lung Injury by Regulating the TLR4/PI3K/Akt/mTOR, Raf-1/MEK/ERK, and Keap1/Nrf2/HO-1 Signaling Pathways in Mice , 2018, Nutrients.

[21]  L. Yao,et al.  PI3K/Akt and HIF-1 signaling pathway in hypoxia-ischemia , 2018, Molecular medicine reports.

[22]  M. Ochani,et al.  B-1a cells protect mice from sepsis-induced acute lung injury , 2018, Molecular medicine.

[23]  Sally A. Abuelezz,et al.  Nebivolol attenuates oxidative stress and inflammation in a guinea pig model of ovalbumin-induced asthma: a possible mechanism for its favorable respiratory effects. , 2018, Canadian journal of physiology and pharmacology.

[24]  B. Chae Pretreatment of Low-Dose and Super-Low-Dose LPS on the Production of In Vitro LPS-Induced Inflammatory Mediators , 2018, Toxicological research.

[25]  A. Otunctemur,et al.  Protective effect of nebivolol on gentamicin-induced nephrotoxicity in rats. , 2018, Bratislavske lekarske listy.

[26]  F. Gultekin,et al.  Positive effects of meal frequency and calorie restriction on antioxidant systems in rats , 2017, Northern clinics of Istanbul.

[27]  M. Hussain,et al.  Nebivolol Attenuates Neutrophil Lymphocyte Ratio: A Marker of Subclinical Inflammation in Hypertensive Patients , 2017, International journal of hypertension.

[28]  Mao Zhang,et al.  Effects of Zinc Finger Protein A20 on Lipopolysaccharide (LPS)-Induced Pulmonary Inflammation/Anti-Inflammatory Mediators in an Acute Lung Injury/Acute Respiratory Distress Syndrome Rat Model , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[29]  Dewei Zhao,et al.  Protective effects of Nebivolol against interleukin-1β (IL-1β)-induced type II collagen destruction mediated by matrix metalloproteinase-13 (MMP-13) , 2017, Cell Stress and Chaperones.

[30]  Hong Jiang,et al.  Propofol inhibits LPS-induced apoptosis in lung epithelial cell line, BEAS-2B. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[31]  F. Kheradmand,et al.  The Role of Matrix Metalloproteinases in Development, Repair, and Destruction of the Lungs. , 2017, Progress in molecular biology and translational science.

[32]  Mushfiquddin Khan,et al.  S‐Nitrosoglutathione ameliorates acute renal dysfunction in a rat model of lipopolysaccharide‐induced sepsis , 2016, The Journal of pharmacy and pharmacology.

[33]  M. Morsy,et al.  Nebivolol Ameliorates Cisplatin‐Induced Nephrotoxicity in Rats , 2016, Basic & clinical pharmacology & toxicology.

[34]  B. Engelhardt,et al.  Lung ICAM‐1 and ICAM‐2 support spontaneous intravascular effector lymphocyte entrapment but are not required for neutrophil entrapment or emigration inside endotoxin‐inflamed lungs , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  Justin Fongemie,et al.  A Review of Nebivolol Pharmacology and Clinical Evidence , 2015, Drugs.

[36]  R. Vandenbroucke,et al.  Is there new hope for therapeutic matrix metalloproteinase inhibition? , 2014, Nature Reviews Drug Discovery.

[37]  J. Tanus-Santos,et al.  β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy. , 2014, Free radical biology & medicine.

[38]  J. Tanus-Santos,et al.  Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension. , 2013, Free radical biology & medicine.

[39]  K. Weber,et al.  Nebivolol: a multifaceted antioxidant and cardioprotectant in hypertensive heart disease. , 2013 .

[40]  K. Lauber,et al.  Matrix metalloproteinases modulate ameboid-like migration of neutrophils through inflamed interstitial tissue. , 2013, Blood.

[41]  J. Kals,et al.  Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension , 2012, Scandinavian journal of clinical and laboratory investigation.

[42]  Qinchuan Li,et al.  Prevention of LPS-Induced Acute Lung Injury in Mice by Progranulin , 2012, Mediators of inflammation.

[43]  E. Bruckert,et al.  Serum levels of adhesion molecules ICAM-1 and VCAM-1 and tissue inhibitor of metalloproteinases, TIMP-1, are elevated in patients with autoimmune thyroid disorders: relevance to vascular inflammation. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[44]  S. T. Rahman,et al.  Effects of nebivolol in obese African Americans with hypertension (NOAAH): markers of inflammation and obesity in response to exercise-induced stress , 2011, Journal of Human Hypertension.

[45]  O. Soehnlein,et al.  Contribution of Neutrophils to Acute Lung Injury , 2011, Molecular medicine.

[46]  C. Mozzini,et al.  Effects of Nebivolol on Endothelial Gene Expression during Oxidative Stress in Human Umbilical Vein Endothelial Cells , 2008, Mediators of inflammation.

[47]  Anne M Manicone,et al.  Matrix metalloproteinases as modulators of inflammation. , 2008, Seminars in cell & developmental biology.

[48]  Rishit Zalawadia,et al.  Nebivolol Reduces Experimentally Induced Warm Renal Ischemia Reperfusion Injury in Rats , 2008, Renal failure.

[49]  T. Risler,et al.  Influence of Nebivolol and Metoprolol on Inflammatory Mediators in Human Coronary Endothelial or Smooth Muscle Cells. Effects on Neointima Formation After Balloon Denudation in Carotid Arteries of Rats Treated with Nebivolol , 2007, Cellular Physiology and Biochemistry.

[50]  K. Ley,et al.  ICAM-1 and LFA-1 play critical roles in LPS-induced neutrophil recruitment into the alveolar space. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[51]  O. Erel,et al.  A new automated colorimetric method for measuring total oxidant status. , 2005, Clinical biochemistry.

[52]  C. Le Quément,et al.  Role of matrix metalloproteinases in the development of airway inflammation and remodeling. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[53]  V. Lagente,et al.  Selective PDE4 inhibitors as potent anti-inflammatory drugs for the treatment of airway diseases. , 2005, Memorias do Instituto Oswaldo Cruz.

[54]  O. Erel A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. , 2003, Clinical biochemistry.

[55]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[56]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[57]  K. Ley,et al.  P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment and injury to the lung and liver. , 1999, The American journal of physiology.

[58]  V. Lagente,et al.  Comparative effects of betamethasone, cyclosporin and nedocromil sodium in acute pulmonary inflammation and metalloproteinase activities in bronchoalveolar lavage fluid from mice exposed to lipopolysaccharide. , 1999, Pulmonary pharmacology & therapeutics.

[59]  C. Delacourt,et al.  Matrix metalloproteinase and elastase activities in LPS-induced acute lung injury in guinea pigs. , 1994, The American journal of physiology.

[60]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[61]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .